Doximity signals FY2027 revenue of $671M-$681M while expanding AI investment with 165 signed health system AI clients (NYSE:DOCS)

Doximity (DOCS) delivered a market-positive earnings signal with FY2027 revenue guidance of $671M–$681M, representing mid-to-high single-digit growth. The expansion of AI client adoption to 165 signed health systems validates the company's enterprise AI strategy and suggests meaningful monetization pathways beyond traditional physician networking services.

The 165 health system AI clients metric is the critical inflection point here. This demonstrates product-market fit in healthcare AI at scale, reducing execution risk around the company's NOHARM (healthcare-specific AI safety framework) differentiation. Margin expansion commentary indicates operating leverage as AI services scale, a hallmark of software-as-a-service transition in healthcare verticals.

The timing of AI search feature rollout and raised guidance suggest management confidence in near-term monetization. This reduces the perception of DOCS as a speculative AI play and elevates it toward validated B2B SaaS growth with institutional healthcare spending underpinning demand.

Sector implication: The news reinforces a broader healthcare digital transformation thesis, particularly around AI-augmented clinical workflows. This supports both software infrastructure (DOCS positioning) and large-cap health IT vendors seeking AI differentiation, while reducing single-company sentiment risk in the healthcare AI space.